work in which it was suggested that 20% of babies in some units had been quite unnecessarily separated from their mothers, which was not to their advantage. He considered that there was a large group of babies who fell between those generally requiring special and intensive care and full-term, obviously normal babies, such as asymptomatic babies in the range of 2-2.5 kg. For these he advocated not an intensive care unit but a transitional care ward, where the mother and child can be nursed together and where, under skilled supervision, the mother can be shown how to care for smaller babies or those with minor symptoms. In Dr Roberton's experience, mothers can be trained to do almost anything that a nurse can do, including tube feeding.
The Health Service personnel concerned with childbirth are many, and it was illuminating to see how different groups were very much concerned with their own internal problems; yet we were presented with very little positive information that would help us in formulating any plan for prevention. It seemed that neither midwives nor health visitors were happy about or certain of their current roles. Where did all this leave us? Many felt that the evidence available is grossly inadequate for formulating policy and, indeed, for deciding who should do what and when. Figures from highly specialized, high-power units with very selective groups of patients can have very little relevance to a general, small, peripheral community.
Dr K A Winship, in discussing the thoughts governing the current DHSS approaches to the problem, revealed what seems to be a very sane, middle-of-the-road approach. She pointed out that the main concern of the' DHSS was the uptake of antenatal services. There is a' need to bring the obstetrician nearer to the patient rather than take the patient to the obstetrician. Dr Winship saw the need for shared care, where the obstetrician could share with the general practitioner the antenatal and follow-up care of mothers nearer their homes. The provision and location of special care units needed considerable rationalization. The majority of such units at the present time have only a 50% occupancy; she felt there was a need for more intensive care cots in regional units but with satellite local units.
One of the most important messages from the meeting seemed to be that in order to reduce the perinatal mortality rate, Social Class V women needed to be brought up to the standards of Social Classes I and II by making certain that they had good antenatal care. It was therefore disconcerting to hear Professor Alberman say that while this would help, what was really needed was better preconceptual carebut we agree with her. Information given to patients about their medicines' More than half the patients who are prescribed medicines do not understand what they are taking, why they need them and how they should be taken. Some action must be taken to correct this potentially dangerous situation by giving simple written instructions supported verbally by doctors and pharmacists. There had been much talk, the. problem was recognized and pilot studies should now be set up to test various schemes, so that the most practicable could be adopted. These were the overall conclusions of a symposium organized by the Medico-Pharmaceutical Forum and held at the Royal Society of Medicine on the 4 June. It was attended by representatives of patients, consumer groups, social workers, manufacturers, pharmacists and doctors.
The problem was clearly defined by Dr P Ley who analysed published studies showing that only 18% of patients were fully informed about their prescribed medicines and 50% could not even understand the label. As might be expected, lack of understanding led to errors in taking medicines.
Examples of such errors were illustrated by Dr Harry Levitt, who pointed out that it was no good asking patients if they understood, as they would rarely admit to confusion, and Dame Elizabeth Ackroyd underlined the way in which instructions could be misunderstood by most patients visiting their doctors. I Report of Medico-Pharmaceutical Forum symposium, Having established the problem and the apparent desire of the patients for more information, it was clear that there was no straightforward solution. Manufacturers appeared to be forced by legislation to give full rather than simple information, and Dr Frank Wells of the British Medical Association feared that this could impair doctorpatient relationships, while Dr Brian Lewis considered that concentration on possible side effects would stop many people taking their medicines at all. Other speakers doubted if full information was a real danger and, although it was not discussed in detail, product liability legislation might force this eventually.
Coming to positive suggestions, many repeated the importance of very simple language on written instructions, which Dr Andrew Herxheimer suggested could be reinforced by suitable diagrammatic symbols. Dr Linda Beeley pointed to the need for verbal reinforcement and Mr D N Sharpe felt that the retail pharmacist was in the ideal position to inform patients, but Dr Donovan and Professor C Fletcher stressed the responsibilities of doctors in this matter.
Dr J M Mungavin of ABPI confirmed the point made by other speakers that pharmaceutical manufacturers were more or less on the side-lines in this matter, as they were limited in their ability to initiate action, but were very willing to comply with practical recommendations. Their position was one of expectancy and hope that this symposium may have brought us a little nearer to a sensible decision.
At the end of a lively discussion, which included the part that could be played by 'original pack' dispensing, separate leaflets, education in schools and the forthcoming new-style British National Formulary, the chairman of the meeting, Professor Desmond Laurence, drew attention to the vast area of common ground and to the considerable discussion going on in the DHSS working party and other places. He reflected the mood of the Medico-Pharmaceutical Forum symposium when he said that we must stop having further meetings which get increasingly boring as they become more repetitive and actually carry out the pilot studies incorporating the suggestions made. Only this experience would allow real progress to be made.
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